Sign In  |  Register  

Search results:

Can't find what you're looking for? Try an Advanced Search

Results 1 to 8 of about 63
These results are based on your search on the following terms:
Text: computational biopharmaceutics
All Journals
Sort by: Relevance | Date
The BCS, BDDCS, and Regulatory Guidances
Author: Mei-Ling Chen, Gordon L. Amidon, Leslie Z. Benet, Hans Lennernas, Lawrence X. Yu

Keywords: BCS,BDDCS,biopharmaceutics classification system,biopharmaceutics drug disposition classification system,drug metabolism,drug permeability
Summary: biopharmaceutics classification biopharmaceutics drug disposition classification system The BCS (Biopharmaceutics Classification System), based

Pharmaceutical Research; Vol. 28 Number 7, Jul 2011;Published Date:06/30/2011; DOI: 10.1007/s11095-011-0438-1
Computational Models to Assign Biopharmaceutics Drug Disposition Classification from Molecular Structure
Author: Akash Khandelwal, Praveen M. Bahadduri, Cheng Chang, James E. Polli, Peter W. Swaan, Sean Ekins

Keywords: BCS,BDDCS,random forest,recursive partitioning,support vector machine
Summary: Computational Models to Assign Biopharmaceutics Drug Disposition BCS, Biopharmaceutics Classification System; A training set of 165 drugs for computational model

Pharmaceutical Research; Vol. 24 Number 12, Dec 2007;Published Date:11/30/2007; DOI: 10.1007/s11095-007-9435-9
Use of the Biopharmaceutical Classification System in Early Drug Development
Author: M. Sherry Ku

Keywords: biopharmaceutics classification,decision tree,formulation,polymorphism,salt
Summary: The Biopharmaceutics Classification System (BCS) is not only a useful tool for obtaining biopharmaceutics classification; decision tree; formulation; polymorphism; salt. in pharmaceutical companies to utilize computational chem-

The AAPS Journal; Vol. 10 Number 1, Mar 2008;Published Date:02/29/2008; DOI: 10.1208/s12248-008-9020-0
PharmRes—More Than the Impact Factor
Author: Vincent H. L. Lee

Summary: Computational biopharmaceutics, proteomics, and

Pharmaceutical Research; Vol. 19 Number 8, Aug 2002;Published Date:07/31/2002; DOI: 10.1023/A:1020127516809
Pharmaceutical Research—Looking Ahead
Author: Peter W. Swaan

Summary: computational and systems biology of drug ADME/Tox will biopharmaceutics.

Pharmaceutical Research; Vol. 26 Number 3, Mar 2009;Published Date:02/28/2009; DOI: 10.1007/s11095-009-9836-z
Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World’s Top Oral Drugs
Author: Arik Dahan, Jonathan M. Miller, Gordon L. Amidon

Keywords: BA/BE,biopharmaceutics classification system,biowaiver,intestinal absorption,molecular biopharmaceutics,oral drug product
Summary: The Biopharmaceutics Classification System (BCS) categorizes drugs into one of four BA/BE; biopharmaceutics classification system; biowaiver; intestinal absorption; molecular biopharmaceutics; oral drug product.

The AAPS Journal; Vol. 11 Number 4, Dec 2009;Published Date:11/30/2009; DOI: 10.1208/s12248-009-9144-x
Crystalline Nanosuspensions as Potential Toxicology and Clinical Oral Formulations for BCS II/IV Compounds
Author: Filippos Kesisoglou, Amitava Mitra

Keywords: bioavailability enhancement,nanocrystals,nanoparticles,nanosizing,nanosuspensions
Summary: oral absorption of Biopharmaceutics Classification System class II and IV compounds. based on the Biopharmaceutics Classification System (BCS) (1) to achieve 1 Biopharmaceutics, Product Value Enhancement, Pharmaceutical Sciences and Clinica

The AAPS Journal; Vol. 14 Number 4, Dec 2012;Published Date:11/30/2012; DOI: 10.1208/s12248-012-9383-0
Drug Discovery and Regulatory Considerations for Improving In Silico and In Vitro Predictions that Use Caco-2 as a Surrogate for Human Intestinal Permeability Measurements
Author: Caroline A. Larregieu, Leslie Z. Benet

Keywords: Biopharmaceutics Classification System (BCS),biowaiver,Caco-2 cells,Food and Drug Administration (FDA),human intestinal permeability,in silico modeling,in vitro screening
Summary: Biopharmaceutics Classification System (BCS); biowaiver; Caco-2 cells; Food and Drug Administration inception of the Biopharmaceutics Classification System (BCS), which originally demonstrated a rela

The AAPS Journal; Vol. 15 Number 2, Apr 2013;Published Date:03/31/2013; DOI: 10.1208/s12248-013-9456-8
<< First | < Previous | | Page 1 of 8 | Next > | Last >>